Literature DB >> 31471817

Calciphylaxis: a conundrum for patients and nephrologists?

Marzia Pasquali1, Natalia De Martini2, Sandro Mazzaferro3,4.   

Abstract

Entities:  

Year:  2019        PMID： 31471817     DOI： 10.1007/s40620-019-00639-6

Source DB:  PubMed          Journal:  J Nephrol        ISSN： 1121-8428            Impact factor:   3.902


× No keyword cloud information.
  10 in total

1.  An experimental model of "dermatomyositis" induced by calciphylaxis.

Authors:  H SELYE; G GENTILE; P JEAN
Journal:  Can Med Assoc J       Date:  1961-09-30       Impact factor: 8.262

2.  Questionable specificity of histologic findings in calcific uremic arteriolopathy.

Authors:  Carla L Ellis; W Charles O'Neill
Journal:  Kidney Int       Date:  2018-06-07       Impact factor: 10.612

3.  Cutaneous calcification in patients with kidney disease is not always calciphylaxis.

Authors:  Sagar U Nigwekar; Rosalynn M Nazarian
Journal:  Kidney Int       Date:  2018-08       Impact factor: 10.612

Review 4.  Calciphylaxis.

Authors:  Sagar U Nigwekar; Ravi Thadhani; Vincent M Brandenburg
Journal:  N Engl J Med       Date:  2018-05-03       Impact factor: 91.245

5.  Improvement in wound healing, pain, and quality of life after 12 weeks of SNF472 treatment: a phase 2 open-label study of patients with calciphylaxis.

Authors:  Vincent M Brandenburg; Smeeta Sinha; Jose-Vicente Torregrosa; Rekha Garg; Stephan Miller; Ana-Zeralda Canals; Daun Bahr; Pieter H Joubert; Carolina Salcedo; Kevin J Carroll; Alex Gold; Joan Perelló
Journal:  J Nephrol       Date:  2019-08-10       Impact factor: 3.902

6.  Survival, Risk Factors, and Effect of Treatment in 101 Patients With Calciphylaxis.

Authors:  James T McCarthy; Rokea A El-Azhary; Michelle T Patzelt; Amy L Weaver; Robert C Albright; Alina D Bridges; Paul L Claus; Mark D P Davis; John J Dillon; Ziad M El-Zoghby; LaTonya J Hickson; Rajiv Kumar; Robert D McBane; Kathleen A M McCarthy-Fruin; Marian T McEvoy; Mark R Pittelkow; David A Wetter; Amy W Williams
Journal:  Mayo Clin Proc       Date:  2016-10       Impact factor: 7.616

7.  News on biomarkers in CKD-MBD.

Authors:  Sandro Mazzaferro; Lida Tartaglione; Silverio Rotondi; Jordi Bover; David Goldsmith; Marzia Pasquali
Journal:  Semin Nephrol       Date:  2014-11       Impact factor: 5.299

8.  Lack of evidence does not justify neglect: how can we address unmet medical needs in calciphylaxis?

Authors:  Vincent M Brandenburg; Pieter Evenepoel; Jürgen Floege; David Goldsmith; Rafael Kramann; Ziad Massy; Sandro Mazzaferro; Leon J Schurgers; Smeeta Sinha; Vicens Torregrosa; Pablo Ureña-Torres; Marc Vervloet; Mario Cozzolino
Journal:  Nephrol Dial Transplant       Date:  2016-03-22       Impact factor: 5.992

9.  SNF472, a novel inhibitor of vascular calcification, could be administered during hemodialysis to attain potentially therapeutic phytate levels.

Authors:  Joan Perelló; M Gómez; M D Ferrer; N Y Rodríguez; C Salcedo; J M Buades; M M Pérez; J V Torregrosa; E Martín; F Maduell
Journal:  J Nephrol       Date:  2018-01-19       Impact factor: 3.902

10.  Treatment of Calciphylaxis in CKD: A Systematic Review and Meta-analysis.

Authors:  Suwasin Udomkarnjananun; Kitravee Kongnatthasate; Kearkiat Praditpornsilpa; Somchai Eiam-Ong; Bertrand L Jaber; Paweena Susantitaphong
Journal:  Kidney Int Rep       Date:  2018-10-09
  10 in total
  1 in total

1.  Setting the clock back: new hope for dialysis patients. Sodium thiosulphate and the regression of vascular calcifications.

Authors:  Massimo Torreggiani; Lurlynis Gendrot; Louise Nielsen; Giorgina Barbara Piccoli
Journal:  J Nephrol       Date:  2021-02       Impact factor: 3.902
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.